Quanterix Corp (NASDAQ:QTRX) Director David R. Walt bought 200,000 shares of the stock in a transaction dated Monday, December 11th. The stock was purchased at an average cost of $15.00 per share, for a total transaction of $3,000,000.00. The acquisition was disclosed in a legal filing with the SEC, which is available at this hyperlink.

Shares of Quanterix Corp (NASDAQ QTRX) traded down $0.08 during trading hours on Wednesday, hitting $19.00. 216,800 shares of the stock traded hands, compared to its average volume of 741,550. Quanterix Corp has a 1-year low of $15.56 and a 1-year high of $19.85.

ILLEGAL ACTIVITY NOTICE: This report was originally posted by American Banking News and is owned by of American Banking News. If you are viewing this report on another site, it was illegally copied and republished in violation of United States and international copyright and trademark laws. The original version of this report can be viewed at https://www.americanbankingnews.com/2017/12/13/quanterix-corp-qtrx-director-david-r-walt-buys-200000-shares.html.

About Quanterix

Quanterix Corporation is a United States-based company, which is a developer of tools in high definition diagnostics. The Company offers single molecule array (Simoa) platform, whcich uses single molecule measurements to access proteins. Simoa focuses on research and clinical testing applications. The Company focuses on research and diagnostics for brain injuries, heart disease, cancer and other diseases with its technology.

Receive News & Ratings for Quanterix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quanterix and related companies with MarketBeat.com's FREE daily email newsletter.